AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26314902
Drug: Gabapentin 800
RxNorm normalized name: gabapentin 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 800 mg (at night and 2 hours prior to induction)
Trial: 8658075
Drug: Powdered acidified
RxNorm normalized name: Acidifiers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powdered acidified full fat cow's milk fortified with 15 mg of iron as ferrous sulfate
Trial: 25133963
Drug: celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: celecoxib 200 mg (qd)
Trial: 16266300
Drug: End-point rectal
RxNorm normalized name: End-Zit
DrugBank: Octasulfur (DB09353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: End-point rectal rewarming temperature at 37.0 degrees C (Group 2)
Trial: 19628959
Drug: Rogerian supportive
RxNorm normalized name: geranium oil, Algerian type
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rogerian supportive therapy (RST)
Trial: 15041600
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg IV
Trial: 9690059
Drug: Inpatient structured
RxNorm normalized name: Impatiens irvingii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient structured diabetes treatment and teaching programme (DTTP)
Trial: 30784669
Drug: Full post-PCI
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full post-PCI bivalirudin infusion (1.75 mg/kg/h for ≤4 h)
Trial: 20042452
Drug: Seawater gel
RxNorm normalized name: Sodium Chloride 2600 mg in 100 mL NASAL SPRAY [NasalAsalt All-Natural Seawater]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seawater gel
Trial: 7936855
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D and phosphate therapy added to Vitamin D alone
Trial: 22205670
Drug: Sodium chlorate
RxNorm normalized name: Sodium Chlorate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium chlorate 150 mg/kg BW
Trial: 21636711
Drug: Postoperative systemic
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative systemic multiagent chemotherapy and intraventricular methotrexate (3 cycles, with possible additional 2 cycles if in complete remission)
Trial: 7955291
Drug: HeartMate 1000
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HeartMate 1000 IP LVAD with no anticoagulants
Trial: 7955291
Drug: HeartMate 1000
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HeartMate 1000 IP LVAD with heparin
Trial: 12209041
Drug: Etoricoxib 90
RxNorm normalized name: etoricoxib 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib 90 mg q.d.
Trial: 26264399
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (daily)
Trial: 21059395
Drug: pCEsa1 DNA
RxNorm normalized name: TOXOPLASMA GONDII DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pCEsa1 DNA vaccine
Trial: 8798310
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (LLETZ and RCDF)
Trial: 11717654
Drug: Low-dose continuous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose continuous combined hormone replacement therapy (0.3 mg conjugated equine estrogens and 2.5 mg medroxyprogesterone acetate plus 1000 mg calcium per day)
Trial: 26006264
Drug: Active Computerized
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active Computerized Control (CC)
Trial: 12685057
Drug: Novel antithrombotic
RxNorm normalized name: antithrombin III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel antithrombotic agents
Trial: 10697082
Drug: Antibiotic-impregnated bone
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic-impregnated bone grafting
Trial: 8123269
Drug: 1% lidocaine
RxNorm normalized name: Icy Hot Max 4%-1% Lidocaine Pain Relief Dry Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% lidocaine with 0.1 mEq/ml of sodium bicarbonate (NaHCO3)
Trial: 21419684
Drug: Post-discharge pharmaceutical
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-discharge pharmaceutical care programme (verbal and written information about treatment)
Trial: 20923790
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (MgSO₄)
Trial: 22512898
Drug: 54 mg
RxNorm normalized name: aspirin 454 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 54 mg OROS-MPH
Trial: 22512898
Drug: 54 mg
RxNorm normalized name: aspirin 454 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 54 mg MPH ER-C
Trial: 16130428
Drug: Bronchodilators (general)
RxNorm normalized name: Bronchodil
DrugBank: Reproterol (DB12846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchodilators (general)
Trial: 23061633
Drug: High oleic
RxNorm normalized name: High Oleic Sunflower Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High oleic safflower oil (HOSF) 2.5 ml p/d for 8 weeks
Trial: 9291856
Drug: Auranofin 3
RxNorm normalized name: auranofin 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auranofin 3 mg b.i.d.
Trial: 16368820
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg tramadol IV injection
Trial: 16698176
Drug: Oxybutynin 5
RxNorm normalized name: oxyBUTYnin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin 5 mg t.i.d.
Trial: 28877711
Drug: Carbon nanoparticles
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbon nanoparticles 10 μg, 50 μg, or 100 μg
Trial: 28877711
Drug: Carbon nanoparticles
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbon nanoparticles 100 μg
Trial: 17259789
Drug: T3-Ibsa oral
RxNorm normalized name: T3
DrugBank: Liothyronine (DB00279)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: T3-Ibsa oral solution
Trial: 16533223
Drug: No maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No maintenance therapy
Trial: 9690953
Drug: (+/-)-sotalol 240
RxNorm normalized name: sotalol hydrochloride 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (+/-)-sotalol 240 mg
Trial: 10073841
Drug: Intravenous vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vitamin K1
Trial: 35075
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving Totamine starting on the day of surgery, providing 1200 calories and 12.4 g of nitrogen per day.
Trial: 31575825
Drug: Caffeine 6
RxNorm normalized name: caffeine 65 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 6 mg·kg‐1
Trial: 17426086
Drug: Physiological testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physiological testosterone administration, 300 mug daily
Trial: 12167274
Drug: Enfuvirtide (T-20)
RxNorm normalized name: Enfuvirtide
DrugBank: Enfuvirtide (DB00109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enfuvirtide (T-20) subcutaneous injection (50 or 100 mg twice daily)
Trial: 15752403
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of thermal indicator into the right atrium
Trial: 14998068
Drug: Rizatriptan 10
RxNorm normalized name: rizatriptan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rizatriptan 10 mg
Trial: 7532930
Drug: Balloon occluded
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balloon occluded arterial infusion (BOAI) treatment
Trial: 16810076
Drug: Fenofibrate and
RxNorm normalized name: Fenofibrate and rosuvastatin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate and control groups (baseline CRP >or=3 mg/dL)
Trial: 23394513
Drug: Fexofenadine at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fexofenadine at 180 mg
Trial: 7195414
Drug: Nalidixic acid
RxNorm normalized name: Nalidixic Acid
DrugBank: Nalidixic acid (DB00779)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nalidixic acid (1 g four times a day) for 3 days
Trial: 22027845
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR 300 mg/day
Trial: 9355077
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil therapy
Trial: 10874258
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of enoxaparin (1 mg/kg) and unfractionated heparin (12,500 IU)
Trial: 28805667
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g of standardized ginger extract per day
Trial: 11505809
Drug: Combined antibiotic
RxNorm normalized name: combinations of different antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined antibiotic and/or antiphlogistic regimen followed by L-Carnitine 1 g x 2/day + acetyl-Carnitine 0.5 g x 2/day for 3 months (A1/B1)
Trial: 26237936
Drug: Both active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both active and control treatments
Trial: 24614995
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 50,000 IU weekly
Trial: 31663816
Drug: Non-anabolic androgen
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-anabolic androgen steroids (AS) users
Trial: 22353811
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and thalidomide
Trial: 28947039
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate 100 μg combined with vilanterol 25 μg (FF/VI)
Trial: 22885164
Drug: Rituximab chemotherapy
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab chemotherapy induction
Trial: 27760081
Drug: Oxybutynin 15
RxNorm normalized name: oxyBUTYnin 15 mg/24 hr oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin 15 mg once daily
Trial: 8625679
Drug: Oral Appliance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Appliance (OA)
Trial: 9990415
Drug: Adapalene 0.1%
RxNorm normalized name: ADAPALENE 0.1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adapalene 0.1% gel
Trial: 22206079
Drug: Tretinoin 0.025%
RxNorm normalized name: TRETINOIN 0.025% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin 0.025% cream
Trial: 28486381
Drug: Concurrent Foley
RxNorm normalized name: CATHETER,FOLEY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent Foley and oxytocin
Trial: 12792359
Drug: Group counseling
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group counseling plus individual drug counseling (IDC)
Trial: 20395096
Drug: Creatine monohydrate
RxNorm normalized name: Creatine Monohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine monohydrate (5 g/day for 8 weeks)
Trial: 8669567
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg
Trial: 3730529
Drug: Promethazine 25
RxNorm normalized name: promethazine 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine 25 mg
Trial: 26400368
Drug: Nintedanib 150
RxNorm normalized name: nintedanib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nintedanib 150 mg twice daily
Trial: 22448810
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg plus mosapride 5 mg
Trial: 16953457
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg alone
Trial: 27762628
Drug: First 100
RxNorm normalized name: Cow first milk
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First 100 shockwaves at 40% power, then 80% power until the end of treatment
Trial: 27762628
Drug: First 100
RxNorm normalized name: Cow first milk
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First 100 shocks at 80% power, followed by a 3‐minute pause, then 80% power until the end of treatment
Trial: 21067018
Drug: Tablet Ciprofloxacin
RxNorm normalized name: ciprofloxacin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet Ciprofloxacin 500 mg
Trial: 21067018
Drug: Injection Ceftriaxone
RxNorm normalized name: ceftriaxone Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection Ceftriaxone 500 mg
Trial: 17984842
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg FTY720 (Group 1)
Trial: 17984842
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg FTY720 (Group 2)
Trial: 19729344
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg glatiramer acetate
Trial: 19544315
Drug: Fluoxetine or
RxNorm normalized name: fluoxetine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine or Nortriptyline
Trial: 14638885
Drug: Pyridostigmine 60
RxNorm normalized name: pyRIDostigmine 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridostigmine 60 mg four times a day for 14 weeks
Trial: 3102414
Drug: Fast neutron
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast neutron therapy
Trial: 8818502
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment of locoregional recurrence
Trial: 22089991
Drug: Sonographic image-guided
RxNorm normalized name: triclosan
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sonographic image-guided injection
Trial: 16831439
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate plus N-acetyl cysteine (50 mg twice per day and 1200 mg/d for 5 days)
Trial: 19608026
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg/day
Trial: 9579625
Drug: 1-stage full-mouth
RxNorm normalized name: SAGE
DrugBank: Sage (DB10982)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-stage full-mouth disinfection (scaling and root planing of all pockets within 24 hours, application of chlorhexidine to all intra-oral niches, chlorhexidine mouth rinsing for 2 months)
Trial: 9579625
Drug: Fractionated periodontal
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractionated periodontal therapy (consecutive root planings per quadrant at a 1 to 2 week interval)
Trial: 9579625
Drug: 1-stage full-mouth
RxNorm normalized name: SAGE
DrugBank: Sage (DB10982)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-stage full-mouth disinfection and fractionated periodontal therapy
Trial: 2764538
Drug: 3-day treatment
RxNorm normalized name: Gyne-Lotrimin 2% 3-Day Treatment Vaginal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-day treatment with enoxacin (200 mg twice a day)
Trial: 23128421
Drug: Rapid Sequence
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid Sequence Induction (RSI) with thiopental 2‐3 mg/kg and remifentanil 1 mcg/kg
Trial: 17000820
Drug: Aspirin gargle
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin gargle (350 mg)
Trial: 29462230
Drug: Oxymetazoline cream
RxNorm normalized name: oxymetazoline Topical Cream
DrugBank: Oxymetazoline (DB00935)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxymetazoline cream 1.5% applied once daily
Trial: 19861283
Drug: Defibrase therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Defibrase therapy (intravenous infusion at doses of 15, 10, and 5 U based on plasma FIB levels)
Trial: 2725277
Drug: Trilostane 240
RxNorm normalized name: TRILOSTANE
DrugBank: Trilostane (DB01108)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trilostane 240 mg/d (Trilo 240)
Trial: 25876706
Drug: Oral OKT3
RxNorm normalized name: Humanized OKT3
DrugBank: Teplizumab (DB06606)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral OKT3 1.0 mg/day (Group C)
Trial: 2574262
Drug: Intramuscular chloroquine
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular chloroquine (3.5 mg base/kg every 6 h)
Trial: 8095573
Drug: Intramuscular artemether
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular artemether
Trial: 25407583
Drug: Face-to-face administered
RxNorm normalized name: FACE SHIELD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Face-to-face administered cognitive behavioral therapy (FtF‐CBT)
Trial: 25003151
Drug: Low-dose remifentanil
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose remifentanil (5 ng · mL(‐1))
Trial: 19100067
Drug: Autoantibodies against
RxNorm normalized name: Humanized IgG4 monoclonal antibody against total complement component 1, subcomponent s
DrugBank: Sutimlimab (DB14996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Autoantibodies against beta(1) adrenergic receptor
Trial: 19100067
Drug: Autoantibodies against
RxNorm normalized name: Humanized IgG4 monoclonal antibody against total complement component 1, subcomponent s
DrugBank: Sutimlimab (DB14996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Autoantibodies against M(2) adrenergic receptor
Trial: 30977312
Drug: Procalcitonin (PCT)
RxNorm normalized name: Procalcitonin
DrugBank: Procalcitonin (DB14812)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procalcitonin (PCT) guided antibiotic discontinuation
Trial: 28007137
Drug: Antiarrhythmic drug
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic drug therapy (ADT)
Trial: 21045074
Drug: Active transdermal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active transdermal nicotine (low dose)
Trial: 17075823
Drug: Ineligible patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ineligible patients (not receiving TNF inhibitors)
Trial: 12532160
Drug: MCT diet
RxNorm normalized name: MCT
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCT diet (67% of treatment fat as MCT oil, 49% octanoate, 50% decanoate)
Trial: 20057309
Drug: Continuous antiretroviral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous antiretroviral therapy (Viral Suppression group)
Trial: 31076187
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg citalopram
Trial: 19037029
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg every 4-6 hours until 37 weeks of gestation)
Trial: 12505741
Drug: Respondents who
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Respondents who indicated they were likely to administer CPR
Trial: 14763548
Drug: Graftjacket tissue
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Graftjacket tissue matrix (single administration)
Trial: 21703900
Drug: Ibandronate 150
RxNorm normalized name: ibandronate 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 150 mg monthly with CTX feedback (Group B)
Trial: 26661906
Drug: Canagliflozin 100
RxNorm normalized name: canagliflozin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canagliflozin 100 mg/Metformin
Trial: 26661906
Drug: Canagliflozin 300
RxNorm normalized name: canagliflozin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canagliflozin 300 mg/Metformin
Trial: 21350803
Drug: Systemic chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic chemotherapy for advanced gastric cancer
Trial: 14633812
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (100 mg/day)